NCT05873348View on ClinicalTrials.gov

A Controlled Study on Regulation of Systemic Inflammation by Fecal Bacteria Transplantation in Patients With COVID-19.

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

March 10, 2023

Study Completion Date

April 30, 2023

Conditions
Fecal Microbiota TransplantationCOVID-19 Infection
Interventions
PROCEDURE

Fecal microbiota transplantation

Fecal microbiota transplantation (FMT) is the use of functional microorganisms in the feces of healthy people to form capsules and orally administer them to the intestinal tract of patients to reconstruct the intestinal flora of patients, so as to achieve the purpose of treating intestinal and exenteric diseases.

Trial Locations (1)

Unknown

Li Long, Shanghai

All Listed Sponsors
lead

Shanghai 10th People's Hospital

OTHER